{"title":"Modulatory role of fucoidan against monosodium glutamate-induced reproductive and hepatorenal toxicity in adult male rats.","authors":"Qurat Ul Ain, Mehwish David, Seemab Younas, Ayesha Batool, Moazama Batool, Fatima Talib","doi":"10.1080/00498254.2026.2683640","DOIUrl":null,"url":null,"abstract":"<p><p>The present study aims to analyse the curative efficacy of fucoidan on MSG mediated changes in hepatorenal and reproductive organs.For this, 42 adult male rats were grouped into six (N = 7animals/group), and treated for 30 consecutive days with following dose regime: Control (saline water), MSG (60 mg/kg), Fucoidan-low-dose (FLD 100 mg/kg), Fucoidan-high-dose (FHD 200 mg/kg), MSG+FLD (60 mg/kg + 100mg/kg) and MSG+FHD (60 mg/kg + 200mg/kg). On day 31, animals were sacrificed, organs were collected, and subjected to sperm parameters, antioxidant enzyme activities, DNA damage and histomorphometric analysis.The findings showed that MSG caused significant decline in sperm parameters and antioxidant enzymes activity, while increasing the concentrations of oxidative stress markers. MSG administration also showed significant DNA damage in sperm, liver and kidney cells. Additionally, adverse histomorphometric changes including damage to seminiferous tubules, caput and caudal epididymal ducts were noted with decline in sperm concentration. Moreover, hepatorenal histological alterations were identified by leukocytic infiltration, cytoplasmic vacuolation in liver and shrinkage of glomerulus and tubular atrophy in the kidney. On contrary, fucoidan treatment reversed all MSG instigated alterations in dose dependent manner.These findings revealed that fucoidan mitigated MSG induced oxidative, genotoxic and histological alterations in rats, suggesting further mechanistic validation for translational relevance.</p>","PeriodicalId":23812,"journal":{"name":"Xenobiotica","volume":" ","pages":"603-619"},"PeriodicalIF":1.5000,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Xenobiotica","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/00498254.2026.2683640","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/6/17 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
The present study aims to analyse the curative efficacy of fucoidan on MSG mediated changes in hepatorenal and reproductive organs.For this, 42 adult male rats were grouped into six (N = 7animals/group), and treated for 30 consecutive days with following dose regime: Control (saline water), MSG (60 mg/kg), Fucoidan-low-dose (FLD 100 mg/kg), Fucoidan-high-dose (FHD 200 mg/kg), MSG+FLD (60 mg/kg + 100mg/kg) and MSG+FHD (60 mg/kg + 200mg/kg). On day 31, animals were sacrificed, organs were collected, and subjected to sperm parameters, antioxidant enzyme activities, DNA damage and histomorphometric analysis.The findings showed that MSG caused significant decline in sperm parameters and antioxidant enzymes activity, while increasing the concentrations of oxidative stress markers. MSG administration also showed significant DNA damage in sperm, liver and kidney cells. Additionally, adverse histomorphometric changes including damage to seminiferous tubules, caput and caudal epididymal ducts were noted with decline in sperm concentration. Moreover, hepatorenal histological alterations were identified by leukocytic infiltration, cytoplasmic vacuolation in liver and shrinkage of glomerulus and tubular atrophy in the kidney. On contrary, fucoidan treatment reversed all MSG instigated alterations in dose dependent manner.These findings revealed that fucoidan mitigated MSG induced oxidative, genotoxic and histological alterations in rats, suggesting further mechanistic validation for translational relevance.
期刊介绍:
Xenobiotica covers seven main areas, including:General Xenobiochemistry, including in vitro studies concerned with the metabolism, disposition and excretion of drugs, and other xenobiotics, as well as the structure, function and regulation of associated enzymesClinical Pharmacokinetics and Metabolism, covering the pharmacokinetics and absorption, distribution, metabolism and excretion of drugs and other xenobiotics in manAnimal Pharmacokinetics and Metabolism, covering the pharmacokinetics, and absorption, distribution, metabolism and excretion of drugs and other xenobiotics in animalsPharmacogenetics, defined as the identification and functional characterisation of polymorphic genes that encode xenobiotic metabolising enzymes and transporters that may result in altered enzymatic, cellular and clinical responses to xenobioticsMolecular Toxicology, concerning the mechanisms of toxicity and the study of toxicology of xenobiotics at the molecular levelXenobiotic Transporters, concerned with all aspects of the carrier proteins involved in the movement of xenobiotics into and out of cells, and their impact on pharmacokinetic behaviour in animals and manTopics in Xenobiochemistry, in the form of reviews and commentaries are primarily intended to be a critical analysis of the issue, wherein the author offers opinions on the relevance of data or of a particular experimental approach or methodology